We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

47 hedge funds and large institutions have $240M invested in Sierra Oncology, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

24% more funds holding

Funds holding: 38 → 47 (+9)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

10% less capital invested

Capital invested by funds: $268M → $240M (-$28M)

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
1.23%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
18
Increased
13
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$7.49M
2
BFA
BlackRock Fund Advisors
California
+$5.98M
3
GT
Greenleaf Trust
Michigan
+$1.59M
4
RIM
RS Investment Management
California
+$1.29M
5
QF
QVT Financial
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
HCM
Hayman Capital Management
Texas
-$8.66M
2
Jennison Associates
Jennison Associates
New York
-$3.09M
3
VM
VHCP Management
New York
-$2.96M
4
Millennium Management
Millennium Management
New York
-$2.28M
5
BA
BlackRock Advisors
Delaware
-$1.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$67.8M – – –
FM
2
Frazier Management
Washington
$32.9M +$37M +54,655 New
O
3
OrbiMed
New York
$29.9M – – –
DM
4
Deerfield Management
New York
$26.9M +$7.49M +11,071 +33%
ASP
5
Adams Street Partners
Illinois
$15.7M – – –
SAM
6
Sectoral Asset Management
Quebec, Canada
$14.4M +$809K +1,195 +6%
RIM
7
RS Investment Management
California
$10.5M +$1.29M +1,914 +12%
RCM
8
RA Capital Management
Massachusetts
$9.1M – – –
BFA
9
BlackRock Fund Advisors
California
$5.32M +$5.98M +8,839 New
Franklin Resources
10
Franklin Resources
California
$3.76M – – –
BBA
11
Baker Bros. Advisors
New York
$3.01M – – –
GT
12
Greenleaf Trust
Michigan
$2.87M +$1.59M +2,345 +97%
VMI
13
VHCP Management II
New York
$2.63M +$2.96M +4,375 New
Federated Hermes
14
Federated Hermes
Pennsylvania
$2.26M – – –
LOAMU
15
Lombard Odier Asset Management (USA)
New York
$1.46M +$65.6K +97 +4%
VM
16
VHCP Management
New York
$1.13M -$2.96M -4,375 -70%
CS
17
Candriam SCA
Luxembourg
$1.07M – – –
QF
18
QVT Financial
New York
$1.05M +$1.18M +1,750 New
PAMU
19
Pictet Asset Management (UK)
United Kingdom
$973K – – –
CAM
20
Cormorant Asset Management
Massachusetts
$799K – – –
CC
21
Caxton Corporation
New Jersey
$688K – – –
AA
22
ALPS Advisors
Colorado
$596K +$670K +990 New
Renaissance Technologies
23
Renaissance Technologies
New York
$587K +$660K +975 New
OPPM
24
Opus Point Partners Management
New York
$451K +$507K +750 New
Swiss National Bank
25
Swiss National Bank
Switzerland
$387K +$435K +643 New
1
2 3

SRRA Hedge Fund Activity: Q4 2015 in Review

47 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q4 2015, worth a combined $240M — down 10% from $268M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SRRA positions and 9 closed out — a net gain of 9 holders — while 13 added to existing stakes and 3 trimmed.

The largest buyer was Deerfield Management, adding an estimated $7.49M. The largest seller was Hayman Capital Management, exiting entirely with an estimated $8.66M sold.

  • 47 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q4 2015, up from 38 in Q3 2015.
  • Funds reported $240M of Sierra Oncology, Inc. Common Stock stock for Q4 2015, down 10% quarter-over-quarter.
  • 18 funds opened new Sierra Oncology, Inc. Common Stock positions in Q4 2015 and 9 closed out, a net change of +9 holders.
  • The largest Sierra Oncology, Inc. Common Stock buyer in Q4 2015 was Deerfield Management, an estimated $7.49M added.
  • The largest Sierra Oncology, Inc. Common Stock seller in Q4 2015 was Hayman Capital Management, an estimated $8.66M sold.

Based on aggregated 13F filings for Q4 2015.